You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 9, September 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (64)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Prognosis/ Outcomes
 •Breast Cancer
 •Alert me on articles by topic

Predictive Factors for Metastatic Involvement of Nonsentinel Nodes in Patients With Breast Cancer

Frans D. Rahusen, MD; Hans Torrenga, MD; Paul J. van Diest, MD,PhD; Rik Pijpers, MD,PhD; Elsken van der Wall, MD,PhD; Jappe Licht, MS; Sybren Meijer, MD,PhD

Arch Surg. 2001;136:1059-1063.

Background  The potential morbidity of an axillary lymph node dissection in patients with breast cancer can be avoided in patients with a negative sentinel node (SN).

Hypothesis  It may be possible to identify a subset of patients with a positive SN and without metastases in the remaining axillary lymph nodes.

Design  Case-control study.

Setting  Both primary and referral hospital care.

Patients  Data were studied for 255 consecutive patients with stage T1 or T2 breast cancer who had a successful identification of the SN.

Interventions  In patients with a positive SN, histological examination of all non-SNs that were negative by routine examination was the same as that for SNs (multiple sectioning and immunohistochemical analysis).

Main Outcome Measures  The incidence of non-SN metastases was correlated with the surface area and number of SN metastases and primary tumor characteristics. A micrometastasis was defined as less than 1 mm2.

Results  Of 255 patients, the SN appeared to be positive in 93 (36%). Subsequent axillary lymph node dissection revealed positive non-SNs in 46 patients (49%). Patients with a single positive SN and patients with metastases less than 1 mm2 in the SN had significantly less non-SN involvement than patients with more than 1 positive SN (40% vs 78%) and patients with macrometastases (27% vs 49%).

Conclusions  The incidence of non-SN metastases seemed to be related to the number of positive SNs and the size of SN metastases. However, in the group of patients with a positive SN, it was not possible to identify a subset of patients without non-SN metastases.


From the Departments of Surgical Oncology (Drs Rahusen, Torrenga, and Meijer), Pathology (Dr van Diest and Mr Licht), Nuclear Medicine (Dr Pijpers), and Oncology (Dr van der Wall), Vrije Universiteit Medical Center, Amsterdam, the Netherlands.


RELATED ARTICLES

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2001;136(9):1089-1090.
FULL TEXT  

This Month in Archives of Surgery
Arch Surg. 2001;136(9):986.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

S-Classification of Sentinel Lymph Node Predicts Axillary Nonsentinel Lymph Node Status in Patients with Breast Cancer
Fink et al.
Ann. Surg. Oncol. 2008;15:848-853.
ABSTRACT | FULL TEXT  

Can Surgical Oncologists Reliably Predict the Likelihood for Non-SLN Metastases in Breast Cancer Patients?
Smidt et al.
Ann. Surg. Oncol. 2007;14:615-620.
ABSTRACT | FULL TEXT  

Risk Factors for Non-Sentinel Lymph Node Metastases in Patients with Breast Cancer. The Outcome of a Multi-institutional Study
Bolster et al.
Ann. Surg. Oncol. 2007;14:181-189.
ABSTRACT | FULL TEXT  

Three-Axillary Lymph Node Sampling for the Prediction of Nonsentinel Node Metastases in Breast Cancer Patients With Sentinel Node Metastases
Motomura et al.
Ann. Surg. Oncol. 2006;13:985-989.
ABSTRACT | FULL TEXT  

Application of intraoperative ultrasound to nonsentinel node assessment in primary breast cancer.
Hsu et al.
Clin. Cancer Res. 2006;12:3746-3753.
ABSTRACT | FULL TEXT  

Validation of a Breast Cancer Nomogram for Predicting Nonsentinel Lymph Node Metastases After a Positive Sentinel Node Biopsy
Lambert et al.
Ann. Surg. Oncol. 2006;13:310-320.
ABSTRACT | FULL TEXT  

Can the Memorial Sloan-Kettering Cancer Center Nomogram Predict the Likelihood of Nonsentinel Lymph Node Metastases in Breast Cancer Patients in The Netherlands?
Smidt et al.
Ann. Surg. Oncol. 2005;12:1066-1072.
ABSTRACT | FULL TEXT  

American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
Lyman et al.
JCO 2005;23:7703-7720.
ABSTRACT | FULL TEXT  

Axillary Sentinel Node and Tumour-related Factors Associated with Non-sentinel Node Involvement in Breast Cancer
Cserni et al.
Jpn J Clin Oncol 2004;34:519-524.
ABSTRACT | FULL TEXT  

Supervised automated microscopy increases sensitivity and efficiency of detection of sentinel node micrometastases in patients with breast cancer
Mesker et al.
J. Clin. Pathol. 2004;57:960-964.
ABSTRACT | FULL TEXT  

Influence of the New AJCC Breast Cancer Staging System on Sentinel Lymph Node Positivity and False-Negative Rates
McCready et al.
JNCI J Natl Cancer Inst 2004;96:873-875.
ABSTRACT | FULL TEXT  

Sentinel Node Biopsy in Breast Cancer Patients: Triple Technique as a Routine Procedure
Torrenga et al.
Ann. Surg. Oncol. 2004;11:231S-235S.
ABSTRACT | FULL TEXT  

Factors affecting metastases to non-sentinel lymph nodes in breast cancer
Fleming et al.
J. Clin. Pathol. 2004;57:73-76.
ABSTRACT | FULL TEXT  

A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy
Van Zee et al.
Ann. Surg. Oncol. 2003;10:1140-1151.
ABSTRACT | FULL TEXT  

Nonvisualization of Axillary Sentinel Node During Lymphoscintigraphy: Is There a Pathologic Significance in Breast Cancer?
Brenot-Rossi et al.
JNM 2003;44:1232-1237.
ABSTRACT | FULL TEXT  

Current Status of Sentinel Lymph Node Mapping and Biopsy: Facts and Controversies
Jakub et al.
The Oncologist 2003;8:59-68.
ABSTRACT | FULL TEXT  

Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients
Cserni
J. Clin. Pathol. 2002;55:926-931.
ABSTRACT | FULL TEXT  

Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance
den Bakker et al.
J. Clin. Pathol. 2002;55:932-935.
ABSTRACT | FULL TEXT  

Sentinel lymph node biopsy in breast cancer
Bonnema and van de Velde
Ann Oncol 2002;13:1531-1537.
ABSTRACT | FULL TEXT  

Sentinel nodal assessment in patients with carcinoma of the lung
Schmidt et al.
Ann. Thorac. Surg. 2002;74:870-875.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.